Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E. Share Price
Equities
RMDA
EGS381B1C015
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1.98 EGP | -0.50% | -5.26% | +20.00% |
Sales 2024 * | 2.92B 62.37M 4.91B | Sales 2025 * | 3.43B 73.3M 5.77B | Capitalization | 2.95B 63.09M 4.97B |
---|---|---|---|---|---|
Net income 2024 * | 381M 8.14M 641M | Net income 2025 * | 512M 10.95M 862M | EV / Sales 2024 * | 1.38 x |
Net Debt 2024 * | 1.07B 22.8M 1.8B | Net Debt 2025 * | 766M 16.38M 1.29B | EV / Sales 2025 * | 1.08 x |
P/E ratio 2024 * |
6.66
x | P/E ratio 2025 * |
5.56
x | Employees | - |
Yield 2024 * |
4.19% | Yield 2025 * |
6.72% | Free-Float | 50.28% |
1 day | -0.50% | ||
1 week | -5.26% | ||
Current month | -3.88% | ||
1 month | -22.66% | ||
3 months | -25.28% | ||
6 months | +30.95% | ||
Current year | +20.00% |
Managers | Title | Age | Since |
---|---|---|---|
Amr Morsy
CEO | Chief Executive Officer | - | 31/12/10 |
Mahmoud Fayek
DFI | Director of Finance/CFO | - | 31/12/18 |
Rania Farouk
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Farida Khamis
BRD | Director/Board Member | - | 31/12/19 |
Director/Board Member | 65 | 31/12/18 | |
Director/Board Member | - | 31/12/10 |
Date | Price | Change | Volume |
---|---|---|---|
14/05/24 | 1.98 | -0.50% | 3 123 296 |
14/05/24 | 1.99 | 0.00% | 1,961,645 |
13/05/24 | 1.99 | +0.51% | 3,385,068 |
12/05/24 | 1.98 | -2.46% | 3,499,406 |
09/05/24 | 2.03 | -1.46% | 5,342,341 |
End-of-day quote Egyptian Exchange, May 14, 2024
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+20.00% | 63.31M | |
+31.37% | 588B | |
-2.60% | 364B | |
+20.83% | 326B | |
+5.69% | 285B | |
+14.83% | 239B | |
+9.93% | 210B | |
-6.95% | 200B | |
+10.77% | 167B | |
+0.10% | 161B |
- Stock Market
- Equities
- RMDA Stock